Samuel Whiting
2021
In 2021, Samuel Whiting earned a total compensation of $836.7K as Chief Medical Officer at OvaScience.
Compensation breakdown
| Non-Equity Incentive Plan | $140,000 |
|---|---|
| Option Awards | $296,737 |
| Salary | $400,000 |
| Total | $836,737 |
Whiting received $400K in salary, accounting for 48% of the total pay in 2021.
Whiting also received $140K in non-equity incentive plan and $296.7K in option awards.
Rankings
In 2021, Samuel Whiting's compensation ranked 9,348th out of 12,415 executives tracked by ExecPay. In other words, Whiting earned more than 24.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,348 out of 12,415 | 25th |
Division Manufacturing | 4,147 out of 5,505 | 25th |
Major group Chemicals And Allied Products | 1,829 out of 2,375 | 23rd |
Industry group Drugs | 1,623 out of 2,096 | 23rd |
Industry Pharmaceutical Preparations | 1,205 out of 1,546 | 22nd |
Source: SEC filing on May 2, 2022.
Whiting's colleagues
We found four more compensation records of executives who worked with Samuel Whiting at OvaScience in 2021.